May 19, 2025

Gauge-Backed Rovia Clinical Research Announces Acquisitions of Delta Research Partners of Bastrop and Delta Research Partners of West Monroe

Southlake, TX – Rovia Clinical Research (“Rovia”), a clinical research site network, is excited to welcome two dedicated clinical research sites in Bastrop, Louisiana and West Monroe, Louisiana to its growing network. Delta Research Partners of Bastrop and West Monroe’s founders and principal investigators, Dr. Raj Bhandari and Dr. Butch Dunn, bring over 30 years of clinical research experience to Rovia and enhance Rovia’s capabilities in the hepatology, gastroenterology and internal medicine space, all while sharing Rovia’s unrelenting commitment to patient centricity and clinical quality. 

Rovia CEO Patricio Casillas highlighted the strategic importance of the Delta acquisitions, noting “Both Dr. Bhandari and Dr. Dunn bring extensive experience, pristine reputations and a shared passion to advancing research in their underserved communities. We are excited for our future ahead and intend to support an expansion of research access throughout the Northern Louisiana market.”

“We are excited to join forces with a partner who shares our commitment for clinical research and will help support our goal to deliver best-in-class research access to our community” said Dr. Bhandari. Dr. Dunn added “With Rovia’s capabilities and resources, we are poised to accelerate growth and continue our commitment to excellence in clinical medicine and clinical research.”

David Friedman, Partner at Gauge Capital, noted “The Delta acquisitions are an important step forward for Rovia and are an ideal cultural and strategic fit for our platform. We look forward to continuing to add like-minded partners to Rovia in the coming years.” 

Rovia Clinical Research is a US-based multi-specialty clinical research site network that partners with healthcare providers, pharmaceutical, biotech, and contract research organizations worldwide. Rovia facilitates clinical trial delivery while delivering exceptional service levels related to study start-up speed, enrollment target achievement and data quality. The company's quality-focused, integrated research services for new drugs, devices, and diagnostic studies are designed to offer improved access and new hope to patients from diverse communities.  With 13 locations and 80 investigators across its network, Rovia aims to continue expanding through acquisitions and strategic partnerships across the United States. 

About Rovia 
Rovia Clinical Research is dedicated to transforming research methodologies and patient care. As a parent company to multiple research sites, Rovia leverages its extensive network to implement innovative approaches in trial management, data analysis, and patient engagement. Committed to scientific excellence and operational efficiency, Rovia is at the forefront of advancements across a range of therapeutic areas. By fostering collaboration among diverse healthcare stakeholders and prioritizing access for underserved communities, Rovia is not just conducting clinical trials—it is shaping the future of medical research and drug development. 
Learn More

About Gauge Capital 
Gauge Capital is a middle-market private equity firm based in Southlake, Texas. Gauge invests in five key sectors: business services, food & consumer, government & industrial services, healthcare, and technology. The Firm manages more than $3.0 billion in capital. For more information, please contact Chris Garvin, Principal, Business Development at cgarvin@gaugecapital.com.